UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human dendritic cell functional specialization in steady-state and inflammation

Frontiers in immunology, 2014-04, Vol.5, p.131-131

2014

Volltextzugriff (PDF)

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Allergy (Copenhagen), 2020-01, Vol.75 (1), p.116-126

2020

Volltextzugriff (PDF)

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Allergy (Copenhagen), 2022-11, Vol.77 (11), p.3398-3407

2022

Volltextzugriff (PDF)

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation

Nature communications, 2021-05, Vol.12 (1), p.2710-2710, Article 2710

2021

Volltextzugriff (PDF)

Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series

Clinical and experimental allergy, 2023-05, Vol.53 (5), p.586-589

2023

Volltextzugriff (PDF)

Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis

Allergy (Copenhagen), 2023-08, Vol.78 (8), p.2266-2276

2023

Volltextzugriff (PDF)

Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation

Clinical and experimental allergy, 2024-04, Vol.54 (4), p.294-296

2024

Volltextzugriff (PDF)

Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients

Clinical and experimental allergy, 2023-02, Vol.53 (2), p.239-243

2023

Volltextzugriff (PDF)

Antigen‐driven PD‐1+TOX+BHLHE40+ and PD‐1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ

European journal of immunology, 2021-04, Vol.51 (4), p.915-929

2021

Volltextzugriff (PDF)

Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies

Clinical and experimental allergy, 2023-05, Vol.53 (5), p.582-585

2023

Volltextzugriff (PDF)

The full spectrum of human naive T cells

Nature reviews. Immunology, 2018-06, Vol.18 (6), p.363-373

2018

Volltextzugriff (PDF)

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

Arthritis & rheumatology (Hoboken, N.J.), 2020-07, Vol.72 (7), p.1214-1226

2020

Volltextzugriff (PDF)

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy

Clinical and experimental allergy, 2024-04, Vol.54 (4), p.241-252

2024

Volltextzugriff (PDF)

Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity

European journal of immunology, 2021-02, Vol.51 (2), p.471-482

2021

Volltextzugriff (PDF)

Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients

Clinical and experimental allergy, 2022-06, Vol.52 (6), p.801-805

2022

Volltextzugriff (PDF)

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry

Pediatric allergy and immunology, 2022-12, Vol.33 (12), p.e13887-n/a

2022

Volltextzugriff (PDF)

T‐cell subsets in the skin and their role in inflammatory skin disorders

Allergy (Copenhagen), 2022-03, Vol.77 (3), p.827-842

2022

Volltextzugriff (PDF)

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases

Frontiers in immunology, 2019-05, Vol.10, p.940-940

2019

Volltextzugriff (PDF)

Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression

Cell reports (Cambridge), 2015-09, Vol.12 (12), p.1986-1996

2015

Volltextzugriff (PDF)

Limited excretion of dupilumab into breastmilk: A case report

Journal of the European Academy of Dermatology and Venereology, 2023-09, Vol.37 (9), p.e1154-e1155

2023

Volltextzugriff (PDF)

Immune monitoring and treatment in immune-mediated inflammatory diseases

Nature communications, 2022-06, Vol.13 (1), p.3245-3245, Article 3245

2022

Volltextzugriff (PDF)

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Scientific reports, 2022-11, Vol.12 (1), p.20675-20675, Article 20675

2022

Volltextzugriff (PDF)

Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency

Journal of clinical immunology, 2021-10, Vol.41 (7), p.1621-1632

2021

Volltextzugriff (PDF)

Human neonatal thymectomy induces altered B‐cell responses and autoreactivity

European journal of immunology, 2017-11, Vol.47 (11), p.1970-1981

2017

Volltextzugriff (PDF)

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

Clinical and translational allergy, 2023-01, Vol.13 (1), p.e12221-n/a

2023

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(136)

Publikationsform

Artikel
(151)
Berichte
(3)

Sprache

Englisch
(154)

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Life Sciences & Biomedicine
(96)
Humans
(73)
Immunology
(50)
Inflammation
(29)
Female
(27)
Male
(25)
Rheumatology
(23)
Animals
(21)
Lymphocytes
(21)
Allergy
(18)
Child
(18)
Biomarkers
(17)
T-Lymphocytes, Regulatory - Immunology
(17)
Atopic Dermatitis
(16)
Lymphocytes T
(15)
Arthritis
(14)
Flow Cytometry
(14)
Mice
(14)
T Cell Receptors
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human dendritic cell functional specialization in steady-state and inflammation

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation

Switching from dupilumab to tralokinumab in atopic dermatitis patients with ocular surface disease: Preliminary case series

Dupilumab‐associated ocular surface disease in atopic dermatitis patients: Clinical characteristics, ophthalmic treatment response and conjunctival goblet cell analysis

Differential dynamics of TARC during JAK‐inhibitor therapy compared to biological therapies targeting type 2 inflammation

Biomarkers in tear fluid of dupilumab‐treated moderate‐to‐severe atopic dermatitis patients

Antigen‐driven PD‐1+TOX+BHLHE40+ and PD‐1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ

Muscle and joint pain during dupilumab treatment for atopic dermatitis: Lack of association with antinuclear antibodies

The full spectrum of human naive T cells

Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis

Ocular surface disease in moderate‐to‐severe atopic dermatitis patients and the effect of biological therapy

Dysregulated RASGRP1 expression through RUNX1 mediated transcription promotes autoimmunity

Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients

Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry

T‐cell subsets in the skin and their role in inflammatory skin disorders

T-Cell Compartmentalization and Functional Adaptation in Autoimmune Inflammation: Lessons From Pediatric Rheumatic Diseases

Inhibition of Super-Enhancer Activity in Autoinflammatory Site-Derived T Cells Reduces Disease-Associated Gene Expression

Limited excretion of dupilumab into breastmilk: A case report

Immune monitoring and treatment in immune-mediated inflammatory diseases

Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3intCD161 + RORγt + ICOS + phenotype, that associates with the presence of ADAMTSL5 autoantibodies

Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency

Human neonatal thymectomy induces altered B‐cell responses and autoreactivity

High dupilumab levels in tear fluid of atopic dermatitis patients with moderate‐to‐severe ocular surface disease

Suchergebnisse filtern